Scotia Capital’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.1K Buy
16,925
+982
+6% +$3.53K ﹤0.01% 896
2025
Q4
$54.5K Sell
15,943
-10,723
-40% -$47.9K ﹤0.01% 879
2025
Q3
$134K Sell
26,666
-2,358
-8% -$10.4K ﹤0.01% 866
2025
Q2
$99.6K Buy
29,024
+12,953
+81% +$32.2K ﹤0.01% 832
2025
Q1
$35.8K Buy
16,071
+947
+6% +$2.72K ﹤0.01% 829
2024
Q4
$44.3K Hold
15,124
﹤0.01% 834
2024
Q3
$39.3K Buy
15,124
+55
+0.4% +$152 ﹤0.01% 819
2024
Q2
$44.6K Hold
15,069
﹤0.01% 810
2024
Q1
$68.3K Buy
+15,069
New +$76.9K ﹤0.01% 801
2022
Q1
Sell
-13,127
Closed -$188K 876
2021
Q4
$188K Sell
13,127
-2,896
-18% -$43.9K ﹤0.01% 817
2021
Q3
$321K Buy
16,023
+1,757
+12% +$31.1K ﹤0.01% 701
2021
Q2
$314K Buy
+14,266
New +$393K ﹤0.01% 709

Other funds holding ABCL